Chemometrically optimized micellar liquid chromatographic method for the simultaneous determination of cetirizine dihydrochloride in its combined dosage forms. Application to biological fluids and pharmacokinetic studies

• Autorzy: Sharaf El Din M. K. , Ibrahim F. , Eid M. I. , Wahba M. E. K.
• Języki publikacji: EN

Abstrakty

EN

An accurate, simple, sensitive, and selective micellar liquid chromatographic method has been developed for the simultaneous determination of cetirizine dihydrochloride in two of its combined pharmaceutical preparations with psudoephedrine hydrochloride and/or paracetamol. The chemometrics approach was applied for the optimization of separation of the studied drugs to optimize their separation; the effect of six experimental parameters on retention was investigated by means of multivariate analysis. Separation was conducted using an ODS C18 (150 × 4.6 mm id) stainless steel column at ambient temperature with UV-detection at 250 nm. A mobile phase composed of 0.135 M sodium dodecyl sulphate, 11% 1-propanol, 0.3% tri-ethylamine in 0.02 M phosphoric acid, and adjusted to pH 3.3 has been used at a flow rate of 1 mL/min. Regression models were characterized by both descriptive and predictive ability (R2 ≥ 98.8% and R2cv ≥ 94.5%) and allowed the chromatographic separation of the drugs with a good resolution and a total analysis time within 6 min.The calibration curves were rectilinear over the concentration ranges of 0.05–1.0, 0.07–4.0, and 1.0–10.0 μg/mL for cetirizine dihydrochloride, psudoephedrine hydrochloride, and paracetamol respectively; with detection limits of 0.01, 0.05, and 0.08 μg/mL, and quantification limits of 0.04, 0.09, and 1.02 μg/mL, respectively. The results obtained were in good agreement with those obtained by the comparison method. Furthermore, the method was applied for the determination of the drugs in spiked human plasma and used to reveal the pharmacokinetic characters in a healthy volunteer treated with oral administration of the studied two combined dosage forms of cetirizine.

Słowa kluczowe

EN

micellar liquid chromatography; chemometric optimization; cetirizine; psudoephedrine; paracetamol; pharmacokinetics

• Wydawca: University of Silesia in Katowice ; Akademiai Kiado
• Czasopismo: Acta Chromatographica
• Rocznik: 2013
• Tom: Vol. 25, no. 1
• Strony: 59--77
• Opis fizyczny: Bibliogr. 22 poz., rys., tab.

Twórcy

autor

Sharaf El Din M. K.

• Mansoura University Department of Analytical Chemistry, Faculty of Pharmacy Mansoura 35516 Egypt

autor

Ibrahim F.

• Mansoura University Department of Analytical Chemistry, Faculty of Pharmacy Mansoura 35516 Egypt

autor

Eid M. I.

• Mansoura University Department of Analytical Chemistry, Faculty of Pharmacy Mansoura 35516 Egypt

autor

Wahba M. E. K.

• Mansoura University Department of Analytical Chemistry, Faculty of Pharmacy Mansoura 35516 Egypt

Bibliografia

• [1] H. Okamoto, T. Nakajima, Y. Ito, T. Aketo, K. Shimada, S. Yamato, J. Pharm. Biomed. Anal., 37, 517 (2005)
• [2] The British Pharmacopoeia. The Stationary Office, London 2008
• [3] S. Sweetman (Ed.) “Martindale: The complete drug reference” Pharmaceutical press. Electronic version: London, 2006
• [4] B.S. Nagaralli, J. Seetharamappa, B.G. Gowda, M.B. Melwanki, J. Chromatogr. B, 798, 49 (2003)
• [5] G.V. Kanumula, B. Raman, M. Sunderesan, Indian Drugs, 38, 294 (2001)
• [6] Q.F. Liao, Z.Y. Xie, B.Y. Pan, C.C. Zhu, M.C. Yao, X.J. Xu, J.Z. Wan, Chromatographia, 67, 687 (2008)
• [7] M.L. Qi, P. Wang, L. Zhou, J.L. Gu, R.N. Fu, Chromatographia, 57, 139 (2003)
• [8] M.L. Qi, P. Wang, L. Zhou, Y. Sun, Chromatographia, 58, 183 (2003)
• [9] K. Nerurkar, U.J. Dhorda, I.C. Bhoir, M. Sundaresan, Indian Drugs, 39, 410 (2002)
• [10] S. Karakus, I. Kucukguzel, S.G. Kucukguzel, J. Pharm. Biomed. Anal., 46, 295 (2008)
• [11] M. Ma, F. Feng, Y.L. Sheng, S.J. Cui, H. Liu, J. Chromatogr. B, 846, 105 (2007)
• [12] Z.R. Tan, D.S. Ouyang, G. Zhou, L.S. Wang, Z. Li, D. Wang, H.H. Zhou, J. Pharm. Biomed. Anal., 42, 207 (2006)
• [13] G. M. Hadada, S. Emarab, W.M.M. Mahmouda, Talanta, 79, 1360 (2009)
• [14] M.D. Rukhadze, V. Rmeyer, J. Chromatogr. A, 805, 45 (1998)
• [15] M.G. Gennaro, D. Giacosa, J. Liq. Chromatogr., 17, 4365 (1994)
• [16] E. Marengo, M.C. Gennaro, Anal. Chim. Acta, 321, 225 (1996)
• [17] A.K. Smilde, A. Knevelman, J. Chromatogr., 369, 1 (1986)
• [18] E. Marengo, M.C. Gennaro, J. Chromatogr. A, 863, 1 (1999)
• [19] United States Pharmacopeial Convention: United States Pharmacopoeia 30; National Formulary 25. US Pharmacopoeia Convention: Rockville, MD; 2007
• [20] Guidance for industry; Q2B of analytical procedure: Methodology; International Conference on Hormonization (ICH), November 2005. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm073384.pdf
• [21] J.C. Miller, J-N. Miller, Statistics for Analytical Chemistry, Wiley; New York. p. 256, 2005
• [22] O. Yin, B. Tomlinson, A.H.L. Chow, M.S.S. Chow, Inter. Journal of Pharm., 222, 305 (2001)